Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users
Mariska Bot, Yuri Milaneschi, Brenda W.J.H. Penninx, et al.
Psychoneuroendocrinology (2016) Vol. 68, pp. 148-155
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
M. Lévy, Fabien Boulle, Harry W.M. Steinbusch, et al.
Psychopharmacology (2018) Vol. 235, Iss. 8, pp. 2195-2220
Open Access | Times Cited: 263
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Alma Y. Gálvez‐Contreras, Tania Campos-Ordoñez, Verónica Lopez-Virgen, et al.
Cytokine & Growth Factor Reviews (2016) Vol. 32, pp. 85-96
Closed Access | Times Cited: 100
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions
Ryan R. Kelly, Lindsay T. McDonald, Nathaniel R. Jensen, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 83
PCOS and Depression: Common Links and Potential Targets
Jagruti V. Kolhe, Abu Sufiyan Chhipa, Shital Butani, et al.
Reproductive Sciences (2021) Vol. 29, Iss. 11, pp. 3106-3123
Closed Access | Times Cited: 75
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
Anna Mosiołek, Jadwiga Mosiołek, Sławomir Jakima, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3377-3377
Open Access | Times Cited: 58
Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice
Gabriela E. Farias Quipildor, Kai Mao, Zunju Hu, et al.
GeroScience (2019) Vol. 41, Iss. 2, pp. 185-208
Open Access | Times Cited: 73
MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?
Reetobrata Basu, Yanrong Qian, John J. Kopchick
European Journal of Endocrinology (2018) Vol. 178, Iss. 5, pp. R155-R181
Open Access | Times Cited: 65
New Insights Into the Comorbidity of Coronary Heart Disease and Depression
Yeshun Wu, Bin Zhu, Zijun Chen, et al.
Current Problems in Cardiology (2019) Vol. 46, Iss. 3, pp. 100413-100413
Closed Access | Times Cited: 58
Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits
Sara G. Higarza, Silvia Arboleya, Miguel Gueimonde, et al.
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0223019-e0223019
Open Access | Times Cited: 51
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 14
Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder
Oleg A. Levada, Alexandra S. Troyan
Annals of General Psychiatry (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 45
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Mahmoud S. Abdallah, Esraa M. Mosalam, Abdel‐Aziz A. Zidan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1897-1906
Open Access | Times Cited: 36
Challenging the Pleiotropic Effects of Repetitive Transcranial Magnetic Stimulation in Geriatric Depression: A Multimodal Case Series Study
Vincenzo Giuseppe Nicoletti, Francesco Fisicaro, Eugenio Aguglia, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 958-958
Open Access | Times Cited: 13
Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia
Hiroshi Arinami, Yuichiro Watanabe, Yutaro Suzuki, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Association between IGF-1 levels and MDD: a case-control and meta-analysis
Xin Qiao, Jiaxin Yan, Zongjun Zang, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism
Kai G. Kahl, Britta Stapel, Helge Frieling
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 89, pp. 146-157
Closed Access | Times Cited: 38
The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review
Carlos Fernández-Pereira, Roberto Carlos Agís‐Balboa
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2561-2561
Open Access
Metabolic Signalling Peptides and Their Relation to Clinical and Demographic Characteristics in Acute and Recovered Females with Anorexia Nervosa
Hiba Mutwalli, Johanna Louise Keeler, Raymond T. Chung, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1341-1341
Open Access
Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man
Andrea Santi, Mariska Bot, André Alemán, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain
Paul L. Mueller, Carolyn E. Pritchett, Tyler N. Wiechman, et al.
Brain Research Bulletin (2018) Vol. 143, pp. 27-35
Closed Access | Times Cited: 29
Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population
Silvia Mahmood, Andrea Evinová, Mária Škereňová, et al.
Central European Journal of Public Health (2016) Vol. 24, Iss. 3, pp. 223-230
Open Access | Times Cited: 20
The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
Alexandra S. Troyan, Oleg A. Levada
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 20
The relation between insulin‐like growth factor 1 levels and risk of depression in ischemic stroke
Wei Zhang, Wo Wang, Li Kuang
International Journal of Geriatric Psychiatry (2017) Vol. 33, Iss. 2
Closed Access | Times Cited: 20
Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
Oleg A. Levada, Alexandra S. Troyan, Ірина Пінчук
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top